DBV Technologies | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amarin USD -25168000 24.64M 2024-09
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
DBV Technologies USD -30328000 3.51M 2024-09
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Incyte USD 205.17M 96.34M 2025-03
Insmed USD -248140000 17.73M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
PTC Therapeutics USD 970.22M 1.03B 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
United Therapeutics USD 382.8M 25.1M 2025-03



DBV Technologies Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.